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Effectiveness of current therapy of bacterial vaginosis
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Abstract: The study was conducted in order to evaluate effectiveness of the treatment of bacterial
vaginosis (BY) with different therapeutic regimes according to recommendations of the World Health
Organi~ion ~WHO). During a one-year period (February 2000-February 2001) the Sexually
Transmatted Dascases (SID) Center was visited by 482 women aged 14-51. The diagnosis of BY was
established by standard methods: Amsel's clinical criteria and Gram stain of vaginal discharge. The
first-line treatment was oral Metronidazole 2g single dose. Second line was Metronidazole 500mg
twice daily orally for 7 days or oral Clindamycin 300 mg twice daily for seven days. BV was
confirmed in 74 women (15.4%). Most often it was observed in women aged 17-30 years of age.
Thiny-threc (44.6% of total) were young women 14-21 years of age. Thirty-one (42%) women
rectived a follow-up examination and of those, II (38. 7%) needed a repeat treatment for BV due to
unsatisfactory results of this treatment. It is concluded that treatment of BY with standard methods
was not always effective with no significant difference between women under 21 years and older
women found in regards to response to treatment. Besides antibiotic treatment, the so-called
Probiotics (Lactobacillus acidophilus) can be taken into consideration as an alternative treatment.
Additional research about the therapeutic effect of this type of drugs is needed.
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INTRODUCTION
Bacterial vaginosis (BV) is one of the most
common infections of the lower genital
tract in women. This condition can be
characterised by a decrease or elimination
of H20 2-producing lactobacilli and an
overgrowth of mixed vaginal flora of
aerobic, anaerobic and micro-aerophilic
species (Gardnerella vaginalis, Mobiluncus,
Bacteroides, Prevotella, Mycoplasma) in
very large numbers. BV is connected with
an increased risk of developing a number of
gynecologic and obstetric complications
such as premature delivery, premature
rupture of amniotic membranes, and pelvic
inflammations. Recently, BV has been
found to promote HIV transmission and the

advent of cervical cancer. The cause of the
appearance of this disorder is unknown. As
a result, the disease cannot be prevented
(1,2).

MATERIAL AND METHODS
Patients who took part in the study came to
the Sexually Transmitted Diseases Center
of the University Hospital of Obstetrics and
Gynaecology "Maychin Dom". The study
was conducted between February 2000 February 2001 with 482 women examined.
The study includes an interview (history), a
gynecological
examination,
and
a
microbiological evaluation. A file was
created for every visitor to the center,
including identification number, age,
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number of visits, previous sexually
transmitted diseases (STDs) and if she
belonged to a risk group (sexual workers,
homosexual, homeless, intravenous drug
users).
The gynecological examination included a speculum survey and an evaluation of
the vaginal discharge - quantity, smell,
color, and presence of purulent discharge
from the cervix. The acidity of the vagina
was measured with a pH-paper (Merck~.
Using a cotton stick, a sample was taken
from the lateral vaginal wall and spread
onto separate slides. On the first slide the
vaginal secretions were mixed with 10%
KOH to perform the amine test, on the
second one - with one drop of saline to
make a wet mount. The third smear was
fixed on a spirit-lamp and Gram-stained.
The preparations were then investigated
under a light microscope with a magnification of 400 and for the colour smear using an immersion technique ·and a
magnification of 1000. A score system for
evaluation of the risk of developing
cervicitis was applied to patients with
vaginal discharge (Table I). If the score
was two points or more these patients were
at high risk (for gonococci and chlamydia
Trachomatis infection) and a therapeutic
scheme was applied.
Table 1. Risk score in patients with vaginal
discharge. Patients with 2 or more points
are considered high risk for cervicitis
Symptomatic partner
(urethral discharge)

2 pts.

- No constant partner
and/or age under 20 years

I pt.

- More then one partner
during the last 3 months

I pt.

- New partner during the
last 3 months

I p.
t

The diagnosis of bacterial vaginosis was
based upon Amsel's clinical criteria and the
results of Gram's staining according to
Nugent's score. The drugs Metronidazole
and Clindamycine orally were used in
patients having BV according to the
therapeutic regimes described in Table 2.
An alternative regime was used in cases of
failure of treatment with Metronidazole 2 g,
cases of allergy to the drug. Clindamycine
was the drug of choice in pregnant women.

Table 2. Therapeutic regimes used in
treatment of B V.
First drug of choice

Alternative regimes

Metronidazole
2glsingle dose,
orally

Metronidazole 500
mg twice daily for
7 days, orally
Clindamycin 300
mg twice daily for
7 days, orally

RESULTS
Out of 482 women, the diagnosis of
bacterial vaginosis was made in I5.4% (74
women). Thirty-three patients (46.6%) were
under 2 I years of age. Twenty three percent
(17 women, 8 under 2Iyears and 9 over 21
years of age) of the patients with BV had
high-risk sexual behaviour. In 30.0% (22
women) BV co-existed with other sexually
transmitted
diseases - (Trichomoniasis,
Condylomata Acuminata, Syphilis Gonorrhea). Pelvic inflammatory dis:ase was
dia?"osed in one case. Thirty-one (42 %)
patients returned to the Center for a followup examination within three weeks of the
initial visit. In 19 (61.3%) of these cases a
no~alization of the vaginal pH and a
h~al~g according to Amsel's and Nugent's
cnt~n~ were established. (Table 3). No
statistically significant difference was
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found between women under 21 and those
older than 21 years. In 12 (38.7%) patients,
a repeat treatment for BV was needed
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because of unsatisfactory results of this
treatment.

Table 3. Effect oftreatment in the different age groups.
Effect of the
treatment

women up to 21 years
n=I5

women over 21 years
n=16

A11 women with
fo1low-up
n=31

Good response of the 10(66.7%)
treatment

9 (56.3%)

19 {61.3%)

Unsatisfactory result 5 (33.4%)
of the treatment

7(43.8%)

12 (38.7%)

Table 4. Sexual transmission ofBV.

FOR:
I. Discovery of G. vaginalis in the urethra
2. Correlation with the number of sexual partners 30 days before the examination.
3. Diminishing of the frequency ofBV in monogamy couples
4. Lack ofBV in virgin girls
AGAINST:
I. Bacteria do not persist in the male urethra.
2. The risk ofBV does not grow with the number of sexual partners.
3. The frequency of relapse does not diminish after treatment of the partner.
4. Discovery of BV. in virgin girls
5. The rectum of women is a reservoir for the microorganisms, associated with BV

DISCUSSION
Bacterial vaginosis (BV) is one of the most
widespread vaginal infections and second in
frequency in Europe, preceded only by
vaginal : candidomycosis. Incidence is
reported to .be anywhere from 4% to 64%
(3). In our study the incidence of BV in our
patient population was 15.4%. There are
many studies of the epidemiology of BV
that shows a connection to sexual activity, a
prior existing trichomoniasis or other sexually transmitted diseases, the use of
contraceptives . and in particular the use of
intrauterine devices as well as black ethnic

groups (4). Whether BV is a sexua1ly
transmitted disease is still an open question.
In the present study 23% of the women
with BV had high-risk sexual behaviour
and in 31.1% the disease was combined
with other STDs. There are many pros and
cons for the classification of BV as a
typical STD. (Table 4). The modem
concept is that BV has the epidemiology of
an STD, but it cannot be included in the list
of the typical STDs (5). The results of
treatment in the present study showed
treatment failure in 38.7% of the cases
(Table 3). Different studies show an
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effectiveness
of Metronidazole
and
Clindamycin therapy ranging from 65% to
99%, but this is only a short-term result (6).
Although antibiotic therapy has been shown
to eliminate BY-associated organisms, there
is an extremely high recurrence rate, with
reports up to 50% of patients experiencing
recurrent infections (7,8). The described
therapeutic regimens are not sufficiently
effective and new treatments need to be
considered.
Evidence points towards recurrence
occurring as a result of failure to establish a
normal flora following antimicrobial
therapy. Lactobacilli are a major component
of normal vaginal microflora. They colonize the epithelium and form a defensive
biofilm, due to their ability to form lactic
acid, hydrogen peroxide, bacteriocins,
Acidophylin, and other antimicrobial
substances (9). Parent and other investigators report evidence of good therapeutic
effect after administration of Lactobacillus
acidophilus for treatment of BV (10,11).
The application of novel molecular methods
in combination with appropriate biological
tests give the opportunity to fmd specific
strains that confer effect and exhibit
immunoadjuvant properties (7). The study
of natural bacteriocinogenic activity and
Probiotics potential of newly isolated
vaginal LAB is a condition to develop new
prep~tions
for clinical application.
Additional studies of the therapeutic effect
of this type of drugs are needed.
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